Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 10 of 38 found articles
 
 
  Corrigendum to Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes. Am J Ophthalmol 2022;234:223-234.
 
 
Title: Corrigendum to Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes. Am J Ophthalmol 2022;234:223-234.
Author: Beykin, Gala
Stell, Laurel
Halim, Muhammad Sohail
Nuñez, Mariana
Popova, Lilia
Nguyen, Bac T.
Groth, Sylvia L.
Dennis, Amy
Li, Zhongqiu
Atkins, Melissa
Khavari, Tom
Wang, Sophia Y.
Chang, Robert
Fisher, Ann C.
Sepah, Yasir J.
Goldberg, Jeffrey L.
Appeared in: American journal of ophthalmology
Paging: Volume 242 () nr. C pages 254
Year: 2022
Contents:
Publisher: Elsevier Inc.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 10 of 38 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands